- Tytuł:
- Safety and clinical activity of autologous RNA chimeric antigen receptor T-cell therapy in myasthenia gravis (MG-001): a prospective, multicentre, open-label, non-randomised phase 1b/2a study
- Autorzy:
- Źródło:
- In The Lancet Neurology July 2023 22(7):578-590
Czasopismo naukowe